Chemed Corporation

CHE NYSE ISIN US16359R1032 SEC CIK 19584 LEI 54930020031IDJT2IM79
Follow Chemed Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $690.9M +10.6% vs same quarter last year
Net income $71.6M +11.5% vs same quarter last year
EPS, diluted $5.45 +22.2% vs same quarter last year
Operating cash flow $56.6M −32.1% vs same quarter last year
Revenue by quarter
$411M
$646.9M
$618.8M
$624.9M
$639.3M
$657.5M
$673.3M
$690.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$2.5B$265.2K
FY24$1.5B$302K
FY23$1.3B$272.5K
FY22$1.2B$249.6K
FY21$1.3B$268.6K
FY20$1.3B$319.5M
FY19$1.3B$219.9M
FY18$1.2B$205.5M
FY17$1.7B$98.2M
FY16$1.6B$108.7M
FY15$1.5B$110.3M
FY14$1.5B$99.3M
FY13$1.4B$77.2M
FY12$1.4B$89.3M
FY11$1.4B$86M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2532.5%13.4%0%
FY24−3%23.9%0%
FY23−11.4%25.9%0%
FY22−14%28.6%0%
FY21−8.6%27.2%0%
FY20−3.3%29.2%23.9%
FY19−3.1%20.1%17.2%
FY18−2.5%20.3%17.2%
FY1731%6.8%5.9%
FY1629.3%11.3%6.9%
FY1529.5%12%7.1%
FY1429%11.6%6.8%
FY1328.6%9.4%5.5%
FY1227.7%10.9%6.2%
FY1128.4%11.3%6.3%
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$325.5M
FY24$368M
FY23$273.4M
FY22$252.6M
FY21$249.9M
FY20$430.5M
FY19$248.2M
FY18$234.3M
FY17$98.2M
FY16$95.6M
FY15$127.4M
FY14$66.7M
FY13$121.5M
FY12$96.5M
FY11$144.8M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$31.7M$431.5M
FY24$27.1M$361.4M
FY23$23.5M$67.7M
FY22$22M$114.5M
FY21$22M$576M
FY20$21.1M$175.6M
FY19$19.8M$92.6M
FY18$18.7M$158.9M
FY17$17.4M$94.6M
FY16$16.4M$102.3M
FY15$15.6M$59.3M
FY14$14.3M$110M
FY13$14.1M$92.9M
FY12$13M$60.6M
FY11$12.5M$144M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Chemed
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearChemedHealthcare median
FY250%−30.6%
FY240%−47%
FY230%−58%
FY220%−80.4%
FY210%−71.9%
FY2023.9%−62.2%
FY1917.2%−46.3%
FY1817.2%−49.6%
FY175.9%−45.9%
FY166.9%−36%
FY157.1%−38.4%
FY146.8%−35.5%
FY135.5%−37.1%
FY126.2%−29.1%
FY116.3%−27.9%